Aryan M Namboodiri Selected Research

Immunoglobulin Gm Allotypes

5/2015	Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma.
1/2014	Genetic variants of IgG1 antibodies and FcγRIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells.
11/2010	Genetic regulation of antibody responses to human epidermal growth factor receptor 2 in breast cancer.
6/2008	Hepatitis C virus core protein discriminates between the two IgG2 allotypes.
7/2007	Fc gamma receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aryan M Namboodiri Research Topics

Disease

9	Neoplasms (Cancer) 01/2020 - 02/2013
7	Infections 01/2020 - 07/2007
6	Breast Neoplasms (Breast Cancer) 08/2018 - 11/2010
4	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 02/2013
2	Carcinogenesis 01/2020 - 01/2020
2	Schizophrenia (Dementia Praecox) 01/2018 - 10/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2022
1	Canavan Disease (Leukodystrophy, Spongiform) 01/2022
1	Cystic Fibrosis (Mucoviscidosis) 11/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Headache (Headaches) 10/2019
1	Myalgia 10/2019
1	Chills 10/2019
1	Neurodevelopmental Disorders 01/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 12/2017
1	Organophosphate Poisoning 12/2017
1	Cognitive Dysfunction 10/2016
1	Glioblastoma (Glioblastoma Multiforme) 05/2015
1	Neuroblastoma 05/2014
1	Adenocarcinoma 08/2013
1	HIV Infections (HIV Infection) 06/2013
1	Malaria 01/2013
1	Coinfection 01/2013
1	Systemic Scleroderma (Systemic Sclerosis) 05/2004

Drug/Important Bio-Agent (IBA)

14	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 11/2008
12	Immunoglobulin G (IgG)IBA 01/2018 - 05/2004
8	AntibodiesIBA 01/2020 - 05/2004
6	Immunoglobulin Km AllotypesIBA 11/2021 - 11/2008
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 02/2013
5	Immunoglobulin Gm AllotypesIBA 05/2015 - 07/2007
4	AntigensIBA 11/2021 - 02/2013
4	Genetic Markers (Genetic Marker)IBA 01/2017 - 06/2008
2	Acetates (Acetic Acid Esters)FDA Link 01/2020 - 01/2020
2	NexusIBA 01/2020 - 01/2020
2	Monoclonal AntibodiesIBA 10/2019 - 01/2018
2	Glycoproteins (Glycoprotein)IBA 08/2018 - 01/2018
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2018 - 08/2013
2	EpitopesIBA 05/2015 - 08/2013
2	ErbB Receptors (EGF Receptor)IBA 05/2015 - 02/2014
1	aspartoacylaseIBA 01/2022
1	KynurenineIBA 01/2020
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2020
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Quinolinic AcidIBA 01/2020
1	VaccinesIBA 01/2018
1	Viral ProteinsIBA 01/2018
1	Isoflurane FDA LinkGeneric 12/2017
1	Cholinergic Agents (Cholinergics)IBA 12/2017
1	Glutens (Glutelin)IBA 10/2016
1	Simplexvirus glycoprotein BIBA 02/2016
1	Immunoglobulin Allotypes (Immunoglobulin Allotype)IBA 05/2015
1	epidermal growth factor receptor VIIIIBA 05/2015
1	Phenylalanine (L-Phenylalanine)FDA Link 05/2014
1	Valine (L-Valine)FDA Link 01/2014
1	Histidine (L-Histidine)FDA Link 12/2013
1	AIDS VaccinesIBA 06/2013
1	Cyclin B1IBA 02/2013
1	human ERBB2 proteinIBA 11/2010

Therapy/Procedure

4	Immunotherapy 02/2016 - 11/2010
1	Therapeutics 06/2022
1	Intravenous Administration 10/2019